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The origin and potential function of corpora amylacea (CA) remains largely unknown. Low
numbers of CA are detected in the aging brain of normal individuals but they are abundant
in the central nervous system of patients with neurodegenerative diseases. In the present
study, we show that CA from patients diagnosed with Alzheimer’s disease (AD) contain
fungal proteins as detected by immunohistochemistry analyses. Accordingly, CA were
labeled with different anti-fungal antibodies at the external surface, whereas the central
portion composed of calcium salts contain less proteins. Detection of fungal proteins
was achieved using a number of antibodies raised against different fungal species, which
indicated cross-reactivity between the fungal proteins present in CA and the antibodies
employed. Importantly, these antibodies do not immunoreact with cellular proteins.
Additionally, CNS samples from patients diagnosed with amyotrophic lateral sclerosis
(ALS) and Parkinson’s disease (PD) also contained CA that were immunoreactive with a
range of antifungal antibodies. However, CA were less abundant in ALS or PD patients as
compared to CNS samples from AD. By contrast, CA from brain tissue of control subjects
were almost devoid of fungal immunoreactivity. These observations are consistent with
the concept that CA associate with fungal infections andmay contribute to the elucidation
of the origin of CA.
Keywords: corpora amylacea, neurodegenerative disease, fungal infection, Alzheimer’s disease, amyotrophic
lateral sclerosis
INTRODUCTION
Corpora amylacea (CA) are glycoproteinaceous inclusions that accumulate in the brain during the
course of normal aging and to a greater extent in some neurodegenerative diseases, particularly
Alzheimer’s disease (AD) (Mrak et al., 1997; Keller, 2006; Song et al., 2014). Abundant CA
are found in a subset of patients with temporal epilepsy, where extensive deposits of CA
replace the pyramidal layers of the cornu ammonis (Nishio et al., 2001; Kovacs and Risser,
2014). In addition to the central nervous system (CNS), CA are found in other organs
and tissues, such as normal prostate glands, prostate cancer and several other malignant
tissues (Christian et al., 2005; Morales et al., 2005; Hechtman et al., 2013a,b; Badea et al.,
2015). CA are amorphous rounded, laminated bodies approximately 10-50µm in diameter.
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The composition of CA has been analyzed in some detail.
They mostly contain polyglucans (over 85% are hexoses) with
a minor component (4%) of proteins (Robitaille et al., 1980;
Nishimura et al., 2000; Sfanos et al., 2009). The rounded
core is formed by different calcium salts, principally calcium
phosphate and calcium oxalate depending on the bodies analyzed
(Magura and Spector, 1979; Nakamura et al., 1995; Kodaka
et al., 2008). A wide range of proteins are found in CA
and a number of them have been characterized using specific
antibodies (Singhrao et al., 1994). For example, ubiquitin, heat-
shock proteins, Bcl-2, and c-Jun (Martin et al., 1991; Cisse
et al., 1993; Botez and Rami, 2001) in addition to tau and
several blood proteins such as thrombospondin-1 and some
complement components may be detected in CA (Singhrao
et al., 1993, 1995; Meng et al., 2009; Day et al., 2015). A
detailed characterization of prostate CA by proteomic analyses
has confirmed that lactoferrin is the most abundant protein,
together with myeloperoxidase, S100 calcium-binding proteins
A8 and A9, which form human calprotectin, and α-defensins,
which form part of neutrophil granules (Sfanos et al., 2009). A
number of S100 proteins including calprotectin, an inflammatory
protein, are also present in CA from normal human brains
(Hoyaux et al., 2000). Indeed, immunohistochemistry analysis
suggests that the source of calprotectin in CA is prostate-
infiltrating neutrophils, leading to the concept that chronic
inflammation results in prostate cancer (De Marzo et al.,
2007; Sfanos et al., 2009, 2014). By contrast, the suggestion
that CA are built up of breakdrown products from neurons
and oligodendroglial cells has also been proposed (Singhrao
et al., 1994). Along this line, proteomic analyses of brain
CA from multiple sclerosis patients detected the presence of
cytoskeleton proteins and glycolysis enzymes (Selmaj et al.,
2008). A number of microorganisms are suggested as the
potential source of the chronic inflammation that triggers
the formation of CA. Among these, several bacteria such as
Chlamydia trachomatis, Escherichia coli, and Pseudomonas spp.,
protozoa such as Trichomonas vaginalis and viruses known
to contribute to different types of cancer, including human
papillomavirus, have been considered (Sfanos et al., 2009,
2014). Furthermore, a correlation between fungal infection and
prostatic cancer has been reported (Sutcliffe et al., 2014). Prostatic
CA are thought to give rise to prostatic calculi, and electron
microscopy examination suggests the presence of microbial
infection (Dessombz et al., 2012). Therefore, the traditional
notion that CA result from precipitated proteins of glandular
secretions is being replaced by the concept that they represent
a response to a microbial infection.
We have recently reported the presence of fungal proteins
in CNS from AD patients (Alonso et al., 2014a; Pisa et al.,
2015a,b), and also in patients diagnosed with amyotrophic lateral
sclerosis (ALS) (Alonso et al., 2015). Fungal infections elicit
a neutrophil response, leading to the production of defensins
and other molecules that participate in the innate immune
response (Cunha et al., 2014; Lionakis, 2014). Neutrophils
play a pivotal role against fungal infections (Lionakis, 2014).
Undoubtedly, lactoferrin is considered a marker of inflammation
and infiltration. Transferrin and lactoferrin are iron-binding
proteins which function to maintain low levels of ferric ions in
blood, mucus and tissues (Johnson andWessling-Resnick, 2012).
In this manner, some microbial infections are controlled since
an increase in free iron leads to microbial growth (Samaranayake
et al., 1997; Bullen et al., 2006; Mehra et al., 2012). Additionally,
both myeloperoxidase and calprotectin are involved in the
control of fungal infections (Murthy et al., 1993; Metzler
et al., 2011). Finally, defensins are a family of small cationic
peptides that can perturb the plasma membrane of C. albicans,
leading to increased membrane permeability (Schroeder et al.,
2011). As indicated above, polyglucans are the most abundant
macromolecule in CA and interestingly these polysaccharides
are also quite abundant in the fungal cell wall (Free, 2013). In
the current study, we assessed the presence of fungal proteins
in CA from different CNS regions obtained from control
individuals and patients with several neurodegenerative diseases.
Our findings provide strong evidence that fungal proteins are
localized in the periphery of CA from patients diagnosed with
neurodegenerative diseases.
MATERIALS AND METHODS
Description of Control Subjects and
Patients
We analyzed samples from patients diagnosed with AD, ALS,
and Parkinson’s disease (PD) in addition to control individuals
without neurological disease. The age and gender of the subjects
investigated in this study are listed in Supplementary Table 1.
All samples were supplied by a brain bank (Banco de Tejidos
CIEN) and were analyzed anonymously. The Ethics Committee
of the Universidad Autónoma de Madrid approved the study.
The transfer of samples was carried out according to national
regulations concerning research on human biological samples.
In all cases, written informed consent was obtained. For
patients with dementia, informed consent for brain donation
was given on a postmortem basis by a next-of-kin following
the procedure established by the external ethical committee
of the brain bank. Accordingly, a next-of-kin of the patient
gave credit through an informed consent document to the
fact that the patient had never opposed to be a brain donor
during his/her life. An ethics committee external to the bank
approved all ethico-legal documents, including written informed
consent.
Brain samples were processed according to a common
postmortem protocol followed by Banco de Tejidos CIEN.
Briefly, rapid neuropathological autopsy was performed upon
call by the donor’s proxies (mean postmortem interval, 4.5 h).
Immediately after extraction, the right half of the brain was
sliced and frozen, while the left half was fixed by immersion
in phosphate-buffered 4% formaldehyde for at least 3 weeks.
A full neuropathological study was performed in the left half
brain after fixation. Neuropathological diagnosis and staging of
all disease entities was performed according to consensus criteria.
Various neuropathological variables related to AD, vascular, Lewy
and TDP (TAR DNA-binding protein) pathologies in addition
to the presence of hippocampal sclerosis were recorded for full
classification of cases.
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Antifungal Antibodies
Candida famata, C. albicans, C. glabrata, and Syncephalastrun
racemosum were grown in YEP (yeast extract peptone) medium
(1% yeast extract, 2% Bacto peptone) as described (Pisa et al.,
2008). Fungal cells were centrifuged and washed in phosphate-
buffered saline (PBS). Phoma betae was purchased from Allergon
AB (Engelholm, Sweden). Fungal cells were autoclaved and
lyophilized. Rabbit antisera against C. famata, C. albicans,
C. glabrata, P. betae, and S. racemosum were obtained by
inoculation of 1 or 2mg of dried fungi in 0.5ml PBS, previously
mixed with an equal volume of Freund’s adjuvant. Rabbits were
inoculated up to three times every 3 weeks and the antibody titer
and specificity of the sera were tested by immunohistochemistry
and immunoblotting using fungal proteins. The protocols
employed were approved by the ethics committee of Centro
de Biologia Molecular “Severo Ochoa” (identification number:
ES280790000180). The optimal dilution for immunofluorescence
staining for each antibody was assayed using both isolated
Candida spp.
The specificity of the antifungal antibodies obtained was
tested by immunofluorescence against different Candida spp.
The cross-reactivity of each antibody against the different
fungal species can differ, for instance anti-C. glabrata antibody
immunoreacted with C. glabrata, C. albicans, C. tropicalis,
C. parapsilosis, and C. Krusei, whereas anti-C. albicans does
not recognize C. Parapsilosis and C. Krusei. By contrast, anti-S.
racemosum only immunoreacts with C. Krusei. Besides, none of
the antifungal antibodies obtained immunoreacted with cultured
human cells or human brain sections from healthy subjects
(Pacheco et al., 2007; Pisa et al., 2015a,b).
Immunohistochemistry Analysis
CNS tissue was embedded in paraffin following standard
techniques and cut into 5-µm sections using a
microtome (Microm HM355s, Walldorf, Germany). For
immunohistochemical analysis, paraffin was removed and
sections were rehydrated and boiled for 2min in 10mM citrate
buffer and then incubated for 10min with 50mM ammonium
chloride. Subsequently, tissue sections were incubated for
10min with PBS/Triton X-100 (0.1%) followed by 20min with
2% bovine serum albumin in PBS. Sections were incubated
overnight at 4◦C with a mouse monoclonal antibody raised
against human α-tubulin (Sigma), human phospho-PHF-tau,
clone AT100 (Thermo Scientific), or human neurofilament
protein, clone 2F11 (Dako), all at 1:50 dilution, or a rabbit
polyclonal antibody raised against proteins obtained from
C. glabrata at 1:500 or C. famata, C. albicans, P. betae, and
S. racemosum at 1:100 dilution. Thereafter, sections were washed
with PBS and further incubated for 1 h at 37◦C with donkey
anti-mouse IgG secondary antibody conjugated to Alexa 555
(Invitrogen) at 1:500 for α-tubulin, tau and neurofilament, and
donkey anti-rabbit IgG secondary antibody conjugated to Alexa
488 (Invitrogen) at 1:500 dilution for antifungal antibodies.
To visualize nuclei, sections were then stained with DAPI (4,6-
diamino-2-fenilindol) (Merck) and treated with autofluorescence
eliminator reagent (Merck). The use of this reagent is important
to avoid autofluorescence, since there is lipofuschin in the aging
brain. All images were collected and analyzed with a LSM710
confocal laser scanning microscope combined with the upright
microscope stand AxioImager.M2 (Zeiss), running Zeiss ZEN
2010 software. The spectral system employed was Quasar +
2 PMTs. Images were deconvoluted using Huygens software
(4.2.2 p0) and visualized with Fiji/ImageJ (NIH, Bethesda, MD)
software.
RESULTS
Fungal Proteins Are Present in CA from AD
Patients
A variety of cellular proteins constitute part of CA (Sfanos
et al., 2009). To assess the presence of fungal proteins in CA,
we carried out immunohistochemistry analysis using a specific
rabbit polyclonal antibody raised against C. glabrata, which
does not cross-react with human proteins (Pisa et al., 2015a,b).
Initially, we tested this antibody on tissue sections from different
CNS regions, including lateral frontal cortex (LFC), cerebellar
córtex (CEC) and entorhinal cortex/hippocampus (ERH) from
one AD patient. Double immunofluorescence staining was
performed using a second antibody that detects tau protein.
CA were more abundant in ERH regions than in LFC or CEC
(Figure 1). CA from all three CNS regions (LFC, CEC, and
ERH) stained positive with the anti-fungal antibody (Figure 1).
The external laminar structures and the envelope surrounding
the central core of CA were clearly immunoreactive for the
C. glabrata antibody (green), revealing the presence of fungal
proteins in this region (Figure 1). In some instances, the entire
envelope was positive, while in other sections only a part of the
external envelope was immunoreactive. By contrast, the anti-tau
antibody (red) stained only some of the CA, particularly from
CEC sections (Figure 1). This result is consistent with previous
findings describing tau protein in CA (Singhrao et al., 1993; Day
et al., 2015). Of note, not all CA contained tau protein inasmuch
as it was undetectable in some CA sections analyzed by confocal
microscopy. Thus, although tau can be detected in some CA, it is
not an abundant protein.
To further assess the presence of fungal proteins in CA, tissue
sections were immunolabeled with additional antibodies raised
against C. famata, C. albicans. S. racemosum, and P. betae (green)
together with a monoclonal antibody against neurofilaments
(red). As shown in Figure 2, CA inclusions from the different
CNS regions from AD patient 1 immunoreacted with all four
antifungal antibodies, further supporting the existence of fungal
proteins in CA. None of the antifungal antibodies recognize
cellular proteins from neural cells in CNS sections (Pisa et al.,
2015a,b). The localization of the immunopositive structures
using the additional antibodies was similar to that observed
with the C. glabrata antibody, strengthening the notion that
fungal proteins are present in CA from different CNS regions. By
contrast, neurofilament staining was more irregular, with strong
immunoreactivity in some CA, and weaker or no staining in
other CA inclusions. This was evident in CEC sections double-
labeled with the anti-C. albicans antibody and in LFC and
CEC sections labeled with the anti-S. racemosum antibody; in
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FIGURE 1 | Corpora amylacea are detected in different regions of the CNS. Tissue sections (5 µm) from different CNS regions of patient AD1 were tested as
follows: lateral frontal cortex (LFC), cerebellar cortex (CEC) and entorhinal cortex/hippocampus (ERH). Immunohistochemistry analysis was carried out by double
immunofluorescence staining employing a rabbit polyclonal anti-C. glabrata antibody (green) and a mouse monoclonal anti-tau antibody (red). Sections were mounted
and observed by confocal microscopy after incubation with the corresponding secondary antibodies, as described in Materials and Methods. Overlapping red and
green pixels appear as orange/yellow. DAPI appears in blue. Scale bar: 10 µm.
both cases, the neurofilament signal was more intense than the
fungal signal, as manifested by the punctate yellow staining
in merged images in some of the sections. The fact that
neurofilaments are detected in some CA but not in others
underscores the concept that the protein composition of CNS CA
is nonhomogeneous. This lack of homogeneity can be revealed
only by immunohistochemistry and not by proteomic analyses of
purified CA.
We also analyzed ERH sections from other AD patients (AD2-
AD11; Supplementary Table 1). Immunohistochemmistry was
performed using anti-C. albicans and anti-P. betae antibodies
(green) and anti-human α-tubulin antibodies were used to mark
microtuble structures (red). Of note, the anti-tubulin antibody
immunoreacts not only with human cells but also with several
eukaryotic species, including fungal cells. Consequently, in the
instances where both green and red signals co-localized, it may
be because of the presence of fungal tubulin. Fungal proteins
were detected in ERH CA inclusions from all 10 additional AD
patients (Figure 3). As the antifungal antibodies are polyclonal,
they can cross-react with a number of fungal proteins. The
positive immunoreactivity with one of these antibodies does not
demonstrate that the fungal species present is the same as that
employed to raise the antibody. However, since each antibody
immunoreacts with different fungal antigens, differences in the
immunostaining provides a clue to indicate that the fungal
species differ. Accordingly, this technique cannot establish
the precise fungal species present in each sample and DNA
sequencing would be required (Alonso et al., 2014a,b; Pisa et al.,
2015b). The majority of the CA inclusions from different patients
immunoreacted with both anti-C. albicans and anti-P. betae
antibodies, although staining for P. betae was more robust in
patients AD3, AD8, AD10, and AD11 than in the other patients
(Figure 3). This finding suggests that the fungal species present
in each patient differ. Additionally these results support the
use of a panel of anti-fungal antibodies to comprehensively
determine the presence or absence of fungal proteins in CA. An
important conclusion from this analysis is that the location of
fungal proteins in CA inclusions rules out the possibility that
fungal infection was due to postmortem contamination since the
formation of CA occurs over long time periods (months or even
years).
Analysis of CA from ALS and PD Patients
Our recent finding of fungal infection in CNS from ALS patients
(Alonso et al., 2015), prompted us to test for fungi in CA
inclusions in ALS samples. We examined tissue sections from
motor cortex (MC), medulla (MD) and different levels of the
spinal cord (SC1, SC2, and SC3) of an ALS patient (ALS1)
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FIGURE 2 | Immunoreactivity of corpora amylacea against different antifungal antibodies. Tissue sections analyzed from patient AD1 are indicated in the
figure. Immunohistochemistry analysis was carried out using a monoclonal antibody to human neurofilaments (red) and rabbit polyclonal antibodies raised against the
following fungi: C. famata, C. albicans. S. racemosum, and P. betae (green). Sections were mounted and examined by confocal microscopy after incubation with the
corresponding secondary antibodies. Orange/yellow corresponds to red and green pixels. DAPI (blue) and scale bar: 10µm.
using anti-C. albicans and anti-P. betae antibodies. Double
immunolabeling of the CNS from patient ALS1 with α-tubulin
(red) revealed fungal proteins (green) at the periphery of CA
inclusions in different regions (Figure 4). Of note, CA inclusions
were also detected in different regions of the CNS of this
patient, including the spinal cord. The numbers of CA inclusions
observed in these samples were, however, lower than those found
in AD patients. We also tested tissue sections from different CNS
regions of five additional ALS patients (ALS2-ALS6) using the
same antibodies. CA inclusions were detected in all ALS patients
examined and all were positive for fungal protein. For clarity,
only one field with each antibody and only one CNS region
for each ALS patient is shown (Figure 4). In general, fungal
proteins (green) were detected at the periphery of CA inclusions,
but in some instances fungal proteins were observed throughout
CA bodies, including the central portion. Additionally, anti-α-
tubulin (red), reactivity was in the main detected in association
with material present in CA, but in a few instances α-tubulin was
detected in the surrounding areas. The observations in ALS tissue
indicate that there is a similarity between ALS CA and AD CA
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FIGURE 3 | Detection of fungal proteins in corpora amylacea from different AD patients. ERH sections from 10 AD patients (AD2-AD11) were incubated with
rabbit polyclonal antibodies against C. albicans and P. betae (green) and a monoclonal antibody against α-tubulin (red). Sections were mounted and examined by
confocal microscopy after incubation with the corresponding secondary antibodies. DAPI and scale bar as in Figure 1.
(Figures 1, 2), and also further support the concept of CA protein
heterogeneity.
We also tested for fungal proteins in CA from brain samples
of one PD patient. As before, several CNS regions were analyzed
using antifungal antibodies (green) and anti-α-tubulin antibodies
(red) (Figure 5). The CNS regions examined in this PD patient
included pons (PN), mesencephalon (MSP), hypothalamus (HT),
callosal body (CB), and caudate and lenticular nuclei (CLN).
CA were also detected in this PD patient and were found in
all CNS regions analyzed. Furthermore, immunoreactive fungal
proteins were prominent in CA bodies and the distribution of
the immunolabels was similar to those observed in ALS and AD
patients. Similarly to ALS patients, the number of CA inclusions
in the different regions examined in the PD patient was much
less than in AD patients. Analysis of CNS samples from five
additional PD patients using anti-C. albicans and anti-P. betae
antibodies is shown in Figure 5. Once again, CA inclusions were
detected in all PD patients analyzed and immunoreactivity to
fungal proteins in these CA was revealed with the two antifungal
antibodies employed. The location of fungal proteins (green) and
the distribution of human α-tubulin were again similar to the
pattern observed with CA from ALS patients.
Study of CA from Control Individuals
It is thought that the formation of CA inclusions are related
to the aging process, even in healthy subjects (Song et al.,
2014). We examined ERH sections from the CNS of five control
subjects using the two antifungal antibodies indicated above. In
general, CA inclusions were clearly much less abundant than
those observed in CNS tissue from patients diagnosed with
neurodegenerative diseases. Nevertheless, the CA inclusions in
control subjects exhibited a modest immunoreactivity against
the two antifungal antibodies employed. For example, CA
from control subjects C2 and C3 immunoreacted with the
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FIGURE 4 | Fungal proteins in corpora amylacea from ALS patients. Tissue sections of patient ALS1 were obtained from the following regions: primary motor
cortex (MC), medulla (MD) and different levels of the spinal cord (SC1, SC2, and SC3) (upper panels). Different regions of the CNS from five additional ALS patients
(ALS2–ALS6) were also analyzed (lower panels). Sections were incubated with rabbit polyclonal antibodies against C. albicans and P. betae (green) and a monoclonal
antibody against α-tubulin (red). Sections were mounted and examined by confocal microscopy after incubation with the corresponding secondary antibodies. DAPI
and scale bar as in Figure 1.
anti-C. albicans antibody, while C4 and, to a lesser extent,
C3 immunoreacted with the anti-P. betae antibody (Figure 6).
Similar to CA from neurodegenerative patients, the external
perimeter of CA exhibited punctate immunoreactivity when
detected; however, the labeling intensity was lower than that
observed in AD patients. These findings indicate that in general
the amount of fungal proteins in CA from control individuals
is much lower than from equivalent neurodegenerative disease
patients and in some cases no immunoreactivity is detected. The
absence of fungal proteins in some CA might be determined
by the particular section examined. Nevertheless, the amount
of fungal proteins in control CA inclusions is very low.
Alternatively, it is theoretically possible that the fungal proteins,
if present, cannot be detected with the antibodies employed in
this study. An estimation of the number and positiveness of CA
in different patients and control subjects is shown in Figure 7.
Certainly, the vast majority of CA from the different patients
analyzed is stained with antifungal antibodies, whereas only a
very minor portion of CA can be considered as positive in
control subjects. On the other hand, in general this quantitation
reveals higher numbers of CA in AD patients, particularly from
ERC areas where CA are more abundant both in patients and
controls. However, one limitation of this quantitation is that
these numbers can vary depending on the specific tissue section
analyzed. As previously noted by other researchers, the amount
of CA is higher close to blood vessels (Nishio et al., 2001).
Collectively, these findings reveal the presence of CA
inclusions in several regions of the CNS from patients with
neurodegenerative diseases. CA are more abundant in the ERH
of AD patients than in other regions but there are higher
quantities of CA from ALS and PD samples than in controls.
Importantly, fungal proteins are detected in CA from all patients
with neurodegenerative diseases tested by means of specific
antibodies.
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FIGURE 5 | Detection of fungal proteins in corpora amylacea from PD patients. Tissue sections of patient PD1 were obtained from the following regions: pons
(PN), mesencephalon (MSP), hypothalamus (HT), callosal body (CB), and caudate and lenticular nuclei (CLN) (upper panels). Different regions of the CNS from five
additional PD patients (PD2-PD6) were also analyzed (lower panels). Sections were incubated with rabbit polyclonal antibodies against C. albicans and P. betae
(green) and a monoclonal antibody against α-tubulin (red). Sections were mounted and examined by confocal microscopy after incubation with the corresponding
secondary antibodies. Overlapping red and green pixels appear as orange/yellow. DAPI and scale bar as in Figure 1.
DISCUSSION
Although great progress has been made in our understanding of
the protein composition of CA inclusions (Sfanos et al., 2014),
a number of components remain unidentified. Furthermore,
the precise origin and potential function of CA inclusions is
obscure and subject to speculation (Mrak et al., 1997; Keller,
2006; Song et al., 2014). The proposal that CA originate through
neurodegeneration is based on findings showing that several
proteins from neural cells can be detected in CA (Singhrao et al.,
1993; Selmaj et al., 2008). Along this line, CA are thought to be
formed by cellular debris and/or breakdown products from brain
cells since cleaved tau protein is found in CA (Day et al., 2015).
Another suggestion is that CA arise from a conglomeration
of proteins that interact after neuron degeneration and
from extravasated blood proteins after breakdown of the
hematoencephalic barrier (Meng et al., 2009). Following this idea,
CA could be envisaged as aggregated proteins and polyglucans,
which together with calcium salts accumulate extracellularly.
Thus, some proteins may form insoluble aggregates that are
integrated as the amyloid component of CA (Kimura et al., 1998;
Vogl et al., 2012). The fact that glial CA inclusions contain
heat-shock proteins, heme oxygenase-1 and ubiquitin suggests
the existence of oxidative stress, perhaps mediated by advanced
glycosylation of cellular proteins (Cisse et al., 1993; Lowe et al.,
1993; Iwaki et al., 1996). The possibility that CA are formed
from mitocondria inside cells and progressively increase in size
leading to cell disruption has also been suggested (Schipper,
2004). Indeed, the expression of heme oxygenase-1 in cultured rat
glial cells induces mitochondrial dysfunction and the formation
of corpuscles reminiscent of CA (Sahlas et al., 2002; Schipper
et al., 2006; Song et al., 2014).
Alternative proposals for the origin of CA center on the
idea that microbial infection with concurrent inflammation is
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FIGURE 6 | Analysis of corpora amylacea present in the CNS of control individuals. Tissue sections from the ERH of five control individuals (C1–C5) were
analyzed by immunohistochemistry. Sections were incubated with rabbit polyclonal antibodies against C. albicans and P. betae (green) and a monoclonal antibody
against α-tubulin (red). Sections were mounted and examined by confocal microscopy after incubation with the corresponding secondary antibodies. Overlapping red
and green pixels appear as orange/yellow. Note the near absence of activity against the fungal antibodies. DAPI and scale bar as in Figure 1.
FIGURE 7 | Quantitation of the number and positiveness of CA from different patients and control subjects. Brain sections from the patients indicated in
the Figure were examined by confocal microscopy and the total number of CA in three different fields was estimated, as well as their staining with anti-P. betae
antibodies. Wide fields were analyzed using 40x magnification. The sections examined were ERC from AD patients and control subjects, MD from ALS patients, PD3
and PD5 and MC from PD4. Red bar: total number of CA in the three fields; blue bar: positive CA with antifungal antibody.
an intrinsic component of CA formation (Heinonen et al., 1992;
Sfanos et al., 2014). In this vein, the present study demonstrates
the existence of fungal proteins in CA from the CNS, but
predominantly in patients diagnosed with neurodegenerative
diseases since the yield in control individuals is very low. These
observations suggest that fungal infection is not necessarily
involved in the formation of CA, however, microbial infections
and particularly mycoses may enhance and/or trigger the
build-up of CA inclusions. Alternatively, if fungal proteins
do not participate in CA formation per se, it is possible
that in tissues infected with fungi, some fungal proteins are
conglomerated together with cellular proteins in these inclusions.
As CA formation occurs progressively, and the location of
these proteins is specific to the CA envelope, the possibility
that fungal infection is caused by postmortem contamination is
unlikely.
The possibility that CA play a role in the pathology of AD
and other diseases has been raised in the literature (Mrak et al.,
1997; Keller, 2006; Schipper et al., 2006; Sfanos et al., 2014). If
correct, it is conceivable that fungal proteins are also implicated
in the severity of symptoms in some of these diseases, mediated
by the formation of larger amounts of CA. The possibility that
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CA, at least in some cases, are formed by mycoses is supported
by several lines of evidence. First, CA contain several salts,
including calcium phosphate and calcium oxalate, and these
salts have also been detected as deposits in fungal infections
(Tanaka et al., 1993; Nakagawa et al., 1999; Modem et al., 2006;
Rassaei et al., 2009). Second, proteins from neutrophil granules
appear in CA and it is well established that fungal infections
elicit a neutrophil response (Murthy et al., 1993; Metzler et al.,
2011; Cunha et al., 2014). Third, polyglucans form a major
component of CA inclusions and this macromolecule is also
an integral constituent of the fungal cell wall and is secreted
to the external medium (Chaffin et al., 1998; Free, 2013). The
finding of keratan sulfate and high mannose glycoconjugates
in CA inclusions was initially interpreted as the result of an
accumulation of glycoconjugates normally present in the brain
tissue matrix through aging (Liu et al., 1987). Nonetheless, it
must also be considered that high mannose glycoconjugates are
also produced by fungal cells (Chaffin et al., 1998). Therefore,
the composition of CA does not discard the possibility that
they are related to fungal infection; rather, it is quite feasible
that they can originate from mycoses. The findings reported
in the present study lend strong support to this possibility.
Interestingly, calprotectin exhibits potent anti-Candida activity
(Sohnle et al., 1996; Okutomi et al., 1998; De Marzo et al., 2007),
and this is also the case for defensin (Schroeder et al., 2011),
an additional component of CA. Given that amyloid β peptide,
which is very abundant in senile plaques, has strong potency
against C. albicans (Soscia et al., 2010), it is conceivable that
an antifungal response occurs in brains from patients diagnosed
with some neurodegenerative diseases. Future work aimed at
purifying and characterizing the range of polysaccharides present
in CA may help to determine whether CA arise as a result of
fungal infection.
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